KIDS 📈 Orthopediatrics - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68752L1008
KIDS: Implants, Instruments, Braces, Screws, Nails, Plates
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. Web URL: https://www.orthopediatrics.com
Additional Sources for KIDS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
KIDS Stock Overview
| Market Cap in USD | 629m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Supplies |
| IPO / Inception | 2017-10-12 |
KIDS Stock Ratings
| Growth 5y | -63.6% |
| Fundamental | -38.7% |
| Dividend | - |
| Rel. Strength Industry | -679 |
| Analysts | 4.17/5 |
| Fair Price Momentum | 18.40 USD |
| Fair Price DCF | - |
KIDS Dividends
No Dividends PaidKIDS Growth Ratios
| Growth Correlation 3m | -55.2% |
| Growth Correlation 12m | -36.5% |
| Growth Correlation 5y | -65.5% |
| CAGR 5y | -12.71% |
| CAGR/Mean DD 5y | -0.39 |
| Sharpe Ratio 12m | -0.73 |
| Alpha | -61.23 |
| Beta | 0.93 |
| Volatility | 55.94% |
| Current Volume | 486.6k |
| Average Volume 20d | 254.6k |
What is the price of KIDS stocks?
As of December 21, 2024, the stock is trading at USD 22.38 with a total of 486,573 shares traded.
Over the past week, the price has changed by +1.18%, over one month by -12.24%, over three months by -22.13% and over the past year by -29.80%.
As of December 21, 2024, the stock is trading at USD 22.38 with a total of 486,573 shares traded.
Over the past week, the price has changed by +1.18%, over one month by -12.24%, over three months by -22.13% and over the past year by -29.80%.
Is Orthopediatrics a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Orthopediatrics (NASDAQ:KIDS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -38.74 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KIDS as of December 2024 is 18.40. This means that KIDS is currently overvalued and has a potential downside of -17.78%.
Probably not. Based on ValueRay Fundamental Analyses, Orthopediatrics (NASDAQ:KIDS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -38.74 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KIDS as of December 2024 is 18.40. This means that KIDS is currently overvalued and has a potential downside of -17.78%.
Is KIDS a buy, sell or hold?
Orthopediatrics has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy KIDS.
Orthopediatrics has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy KIDS.
- Strong Buy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for KIDS stock price target?
According to ValueRays Forecast Model, KIDS Orthopediatrics will be worth about 20.4 in December 2025. The stock is currently trading at 22.38. This means that the stock has a potential downside of -8.85%.
According to ValueRays Forecast Model, KIDS Orthopediatrics will be worth about 20.4 in December 2025. The stock is currently trading at 22.38. This means that the stock has a potential downside of -8.85%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 40.7 | 81.7% |
| Analysts Target Price | 56.7 | 153.2% |
| ValueRay Target Price | 20.4 | -8.8% |